It really is going to be interesting how this unfolds.
It really is going to be interesting how this unfolds. There are just so many possibilities in how this shakes down. I will give Leo a ton more credit than most because I believe he has done an unbelievable job taking this company thru 7 successful human trials and hopefully in the next 30 days the tally will be 8! And doing that with only diluting 50 million-ish since I have been involved.
I have been feeling a difference in tone and PR style for quite some time and I feel that is because major eyes and discussions have been taking place.
50 Million shares is nothing to go from PRE-CLINICAL with really only 2 drugs (P and K) to 8 SUCCESSFUL HUMAN clinical trials and adding Brilacidin which has the potential of WHO knows how many indications it can treat!!! And 3 of those 8 trials will put those drugs into phase 3 (B-ABSSSI - P for psoriasis - B-OM)
I feel B-OM will be first to partner, however there is a gut feeling that Kevetrin may jump in front after the successful phase 2 Ovarian trial. It would be a very small deal with heavy backend and royalties but the BP industry cannot ignore what Kevetrin is doing - it;s the ORAL formulation and that UNKNOWN is what hinders a HUGE deal......like today. So does Leo feel more value can be gained if Dr. M can get it straight.....or do they want to move fast with more power and knowledge to help with the formulation? It seems like the formulation is almost confirmed so who knows.......But either way we are part of a company that is producing the first NON_TOXIC P53 altering drug.
It will be interesting if we don't hear news for the upcoming weeks leading into the DATA lock PR for P. IPIX has their hands full that is for sure!
LONG AND STRONG!
12
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...
Continue Reading
Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...
Continue Reading
Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...
Continue Reading
All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...
Continue Reading
Maxwell Joins VT Markets Amid Strategic Shift Forget the usual humdrum of C-suite comings and goings; this one's packed with punch. VT Markets is setting the stage for a serious leap forward by naming Ross Maxwell their new Chief Strategy Officer. This isn't just another desk job—it's a pivotal role meant to integrate cutting-edge technology with the ever-evolving...
Continue Reading
Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...
Continue Reading
When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...
Continue Reading
The java crowd is waking up to a new trend that's more than just a flash in the mug. We're looking at a market shift where the decaffeinated coffee scene is steaming ahead, geared up for a whopping $5.2 billion valuation by 2031, growing at a tidy 7% CAGR. Yeah, you read that right. So, what's brewing that's making this market percolate? Riding the Wave of...
Continue Reading
Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...
Continue Reading
Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....
Continue Reading
Top 5 Most Recently Viewed Articles
Reddit Faces Major Service Disruption Recently, Reddit, a widely-used social media platform, encountered a significant outage that affected thousands of users. This disruption came shortly after the company had implemented a fix for a software error that had prevented numerous users from accessing the site. Details of the Outage According to reports from outage tracking...
Continue Reading
Symbotic Inc. Under Investigation for Securities Violations There has been a significant development for investors of Symbotic Inc. As concerns about the Company’s financial practices have arisen, the Schall Law Firm has initiated an investigation. This effort is aimed at ensuring shareholders are informed and protected amid allegations of misleading statements related...
Continue Reading
TGS Launches Groundbreaking 3D Streamer Project for Summer 2025 TGS, a prominent player in the energy data and intelligence sector, is thrilled to announce its first 3D streamer contract scheduled for the summer season of 2025. Acquisition efforts are set to begin in May, with the entire project expected to span approximately 35 days. This exciting development marks a...
Continue Reading
SK Telecom and Schneider Electric Unite for Innovation SK Telecom (NYSE: SKM) recently solidified a strategic partnership with Schneider Electric, a notable name in the fields of energy management and automation, during a showcase at the Mobile World Congress. This partnership aims to amplify the capabilities of artificial intelligence data centers (AIDCs) significantly....
Continue Reading
Investigation of ADMA Biologics Generates Investor Attention In a shocking turn of events, ADMA Biologics Inc (NASDAQ: ADMA) has caught the attention of legal experts and investors alike. After the abrupt resignation of its independent auditor, CohnReznick LLP, the company is now under scrutiny. This change has caused a stir among stakeholders, leading to a substantial...
Continue Reading